In addition, downregulation of c-IAP1 and c-IAP2, which leads to the inhibition of NF-κB activation, could enhance the chemosensitivity of CRC cells to CPT-11 (Yu et al. 2014). This evidence concerns the gene BIRC3 and colorectal carcinoma.